These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 347303)
1. WHO looks for benefits from genetic engineering. Newmark P Nature; 1978 Apr; 272(5655):663-4. PubMed ID: 347303 [No Abstract] [Full Text] [Related]
2. The recombinant DNA scenarios: Andromeda strain, chimera, and Golem. Davis BD Am Sci; 1977; 65(5):547-55. PubMed ID: 334004 [No Abstract] [Full Text] [Related]
3. Public of 2 minds on genetic shifts. Schneider K N Y Times Web; 1987 May; ():21. PubMed ID: 11646570 [No Abstract] [Full Text] [Related]
4. Will the DNA guidelines wither away? Nature; 1980 Oct; 287(5782):473-4. PubMed ID: 6999363 [No Abstract] [Full Text] [Related]
5. Biotechnology: history shapes German opinion. Meyer P Forum Appl Res Public Policy; 1991; 6(4):92-8. PubMed ID: 11654868 [No Abstract] [Full Text] [Related]
6. Codex guidelines for GM foods include the analysis of unintended effects. Haslberger AG Nat Biotechnol; 2003 Jul; 21(7):739-41. PubMed ID: 12833088 [No Abstract] [Full Text] [Related]
7. Evolution of the NIH guidelines. Milewski EA Recomb DNA Tech Bull; 1981 Dec; 4(4):160-5. PubMed ID: 7029672 [No Abstract] [Full Text] [Related]
8. Gene industry fails to win hearts and minds. Coghlan A New Sci; 1993 Jun; 138(1878):4. PubMed ID: 11656234 [No Abstract] [Full Text] [Related]
9. Genetic engineering: benefits and dangers. WHO Chron; 1978 Dec; 32(12):465-8. PubMed ID: 282708 [No Abstract] [Full Text] [Related]
10. Seeking wisdom in recombinant DNA research. Berg P; Singer M Fed Proc; 1976 Dec; 35(14):2542-3. PubMed ID: 1068802 [No Abstract] [Full Text] [Related]
11. Regulating genetic engineering in an era of increased judicial deference: a proper balance of the federal powers. Von Oehsen WH Adm Law Rev; 1988; 40(3):303-44. PubMed ID: 11650827 [No Abstract] [Full Text] [Related]
12. Public regulation of recombinant dna gene therapy. McGarity TO; Shapiro SA J Leg Med; 1982 Jun; 3(2):185-210. PubMed ID: 6981676 [No Abstract] [Full Text] [Related]
13. Recombinant DNA research; actions under guidelines; notice. U.S. National Institutes of Health Fed Regist; 1985 Mar; 50(47):9760-7. PubMed ID: 11655783 [No Abstract] [Full Text] [Related]
14. Asilomar's legacy in Aotearoa New Zealand. Rogers-Hayden T Sci Cult (Lond); 2005 Dec; 14(4):393-410. PubMed ID: 16622954 [No Abstract] [Full Text] [Related]
15. Let us stop regulating DNA research. Watson JD Nature; 1979 Mar; 278(5700):113. PubMed ID: 368654 [No Abstract] [Full Text] [Related]
16. DNA: have the corporations already grabbed control of new life forms? Rifkin J Mother Jones; 1977; 2(2):23-39. PubMed ID: 11649384 [No Abstract] [Full Text] [Related]
17. Avoiding frankendrugs. Singer PA; Daar AS Nat Biotechnol; 2000 Dec; 18(12):1225. PubMed ID: 11101759 [No Abstract] [Full Text] [Related]
18. Who should control recombinant DNA? Fields CM Chron High Educ; 1977 Mar; 14(4):1+. PubMed ID: 11661400 [No Abstract] [Full Text] [Related]
19. How Should Risk-Based Regulation Reflect Current Public Opinion? Pollock CJ Trends Biotechnol; 2016 Aug; 34(8):604-605. PubMed ID: 27266813 [TBL] [Abstract][Full Text] [Related]
20. The hazard that disappeared. Lancet; 1979 May; 1(8126):1123-4. PubMed ID: 86840 [No Abstract] [Full Text] [Related] [Next] [New Search]